共 204 条
[1]
Fujita Y(2017)Metformin: new preparations and nonglycemic benefits Curr Diab Rep 17 5-283
[2]
Inagaki N(2017)Growth differentiation factor 15 as a novel biomarker for metformin Diabetes Care 40 280-448
[3]
Gerstein HC(2020)GDF15 mediates the effects of metformin on body weight and energy balance Nature 578 444-1029
[4]
Pare G(2003)Macrophage inhibitory cytokine-1: a novel biomarker for p53 pathway activation Mol Cancer Ther 2 1023-1709
[5]
Hess S(2018)Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial Eur J Heart Fail 20 1701-1333
[6]
Ford RJ(2016)Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study Eur Heart J 37 1325-333
[7]
Sjaarda J(2017)Growth differentiation factor 15 predicts all-cause morbidity and mortality in stable coronary heart disease Clin Chem 63 325-1604
[8]
Raman K(2012)Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study Circulation 126 1596-338
[9]
Coll AP(2019)The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure Clin Res Cardiol 109 331-22
[10]
Chen M(2003)‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32 1-90